Green Cross Medical Science Corporation (142280) — Cash Flow Quality Index
Green Cross Medical Science Corporation (142280) has a Cash Flow Quality Index of 13.57x as of December 2025. Operating cash flow of ₩5.01 Billion exceeds net income of ₩369.44 Million, indicating high earnings quality where cash backs reported profits. Explore Green Cross Medical Science Corporation (142280) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Green Cross Medical Science Corporation Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Green Cross Medical Science Corporation across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Green Cross Medical Science Corporation tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Green Cross Medical Science Corporation (2014–2025)
Year-by-year earnings quality comparison for Green Cross Medical Science Corporation. For live market cap and the full company financial profile, see 142280 market cap overview.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.96x | ₩7.20 Billion | ₩3.67 Billion | ▲ +82.1% |
| 2024 | 1.08x | ₩3.66 Billion | ₩3.40 Billion | ▼ -52.3% |
| 2023 | 2.26x | ₩4.24 Billion | ₩1.88 Billion | ▲ +273.3% |
| 2020 | -1.30x | ₩-8.76 Billion | ₩6.72 Billion | ▲ +85.6% |
| 2015 | -9.03x | ₩-5.45 Billion | ₩603.26 Million | ▼ -1412.9% |
| 2014 | -0.60x | ₩-2.22 Billion | ₩3.72 Billion | — |